Zegerid Otc Capsules



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 51.1%
Medical Observation 14.2%
Gastrooesophageal Reflux Disease 11.2%
Dyspepsia 8.3%
Depression 1.9%
Hypertension 1.6%
Anxiety 1.3%
Arthritis 1.3%
Blood Cholesterol Increased 1.3%
Hypersensitivity 1.1%
Barrett's Oesophagus 0.8%
Gastritis 0.8%
Hypothyroidism 0.8%
Pain 0.8%
Thyroid Disorder 0.8%
Atrial Tachycardia 0.5%
Blood Cholesterol 0.5%
Blood Pressure 0.5%
Fibromyalgia 0.5%
Fluid Retention 0.5%
Overdose 31.5%
Drug Ineffective 15.3%
Nausea 6.5%
Inappropriate Schedule Of Drug Administration 5.6%
Abdominal Pain Upper 3.2%
Incorrect Drug Administration Duration 3.2%
Prescribed Overdose 3.2%
Product Physical Issue 3.2%
Wrong Technique In Drug Usage Process 3.2%
Adverse Event 2.4%
Condition Aggravated 2.4%
Drug Effect Decreased 2.4%
Off Label Use 2.4%
Rash 2.4%
Somnolence 2.4%
Therapeutic Response Unexpected 2.4%
Unevaluable Event 2.4%
Vomiting 2.4%
Dysphagia 1.6%
Expired Drug Administered 1.6%
Secondary
Product Used For Unknown Indication 32.2%
Medical Observation 21.9%
Gastrooesophageal Reflux Disease 13.8%
Dyspepsia 7.4%
Arthritis 3.5%
Depression 2.6%
Hypertension 2.6%
Ill-defined Disorder 2.3%
Pain 1.6%
Abdominal Pain Upper 1.3%
Anxiety 1.3%
Chills 1.3%
Diabetes Mellitus 1.3%
Hypersensitivity 1.3%
Vomiting 1.3%
Barrett's Oesophagus 1.0%
Blood Cholesterol Increased 1.0%
Gastritis 1.0%
Ulcer 1.0%
Anaemia 0.6%
Overdose 41.8%
Prescribed Overdose 8.9%
Inappropriate Schedule Of Drug Administration 6.3%
Drug Ineffective 5.1%
Nausea 5.1%
Condition Aggravated 3.8%
Product Physical Issue 3.8%
Wrong Technique In Drug Usage Process 3.8%
Abdominal Pain Upper 2.5%
Dysgeusia 2.5%
Nervousness 2.5%
Off Label Use 2.5%
Unevaluable Event 2.5%
Adverse Event 1.3%
Heart Rate Increased 1.3%
Oedema Peripheral 1.3%
Product Colour Issue 1.3%
Product Quality Issue 1.3%
Rash 1.3%
Renal Disorder 1.3%
Concomitant
Product Used For Unknown Indication 75.5%
Blood Cholesterol 3.8%
Blood Pressure 3.8%
Hypersensitivity 3.8%
Hypothyroidism 3.8%
Local Swelling 3.8%
Restless Legs Syndrome 3.8%
Medical Observation 1.9%
Inappropriate Schedule Of Drug Administration 33.3%
Incorrect Dose Administered 33.3%
Ulcer Haemorrhage 33.3%